PTAFR Knockout A-549 Cell Line
Cat.No.:
EDC07964
Species:
Human
Cell Name:
A-549
Gene:
PTAFR
Gene ID:
5724
Size:
1×10⁶cells
PTAFR Knockout Cell Line (A549) is an exclusive upgraded CRISPR/Cas9 system-mediated gene knockout cell, with the advantages of Optimized Strategy Design, Efficient Cell Transfection, High-Performance Cas9 Protein and Hassle-Free Cell Selection.
| Cat.No. | EDC07964 |
|---|---|
| Product Name | PTAFR Knockout A549 Cell Line |
| Cell Line | A-549 |
| Cellosaurus ID | CVCL_0023 |
| Cell Line Synonyms | A 549, A549, NCI-A549, A549/ATCC, A549 ATCC, A549ATCC, hA549 |
| Gene | PTAFR |
| NCBI Gene ID | |
| Gene Synonyms | PAFR |
| Summary |
This gene encodes a seven-transmembrane G-protein-coupled receptor for platelet-activating factor (PAF) that localizes to lipid rafts and/or caveolae in the cell membrane. PAF (1-0-alkyl-2-acetyl-sn-glycero-3-phosphorylcholine) is a phospholipid that plays a significant role in oncogenic transformation, tumor growth, angiogenesis, metastasis, and pro-inflammatory processes. Binding of PAF to the PAF-receptor (PAFR) stimulates numerous signal transduction pathways including phospholipase C, D, A2, mitogen-activated protein kinases (MAPKs), and the phosphatidylinositol-calcium second messenger system. Following PAFR activation, cells become rapidly desensitized and this refractory state is dependent on PAFR phosphorylation, internalization, and down-regulation. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2011]
|
| Associated Diseases | Non-Small Cell Lung Carcinoma |
| Morphology | Adherent |
| Passage Ratio | 1/5-1/4 ,2days |
| Complete Culture Medium | F-12K + 10% FBS |
| Freezing Medium | 95% Complete culture medium + 5% DMSO |
| QC | Indels validated by Sanger sequencing; sterility confirmed via microbial testing. |
* For research use only. Not intended for use in humans or animals, including clinical, therapeutic, or diagnostic purposes.
| Loci | STR Info (Sample Cell) Sample Cell Line: A-549 | STR Info (Cell bank) Cell Line: A-549 | ||
| Allele1 | Allele2 | Allele1 | Allele2 | |
| Amelogenin | X | Y | X | Y |
| CSF1PO | 10 | 12 | 10 | 12 |
| D2S1338 | 24 | 24 | ||
| D3S1358 | 16 | 16 | ||
| D5S818 | 11 | 11 | ||
| D7S820 | 8 | 11 | 8 | 11 |
| D8S1179 | 13 | 14 | 13 | 14 |
| D13S317 | 11 | 11 | ||
| D16S539 | 11 | 12 | 11 | 12 |
| D18S51 | 14 | 17 | 14 | 17 |
| D19S433 | 13 | 13 | ||
| D21S11 | 29 | 29 | ||
| FGA | 23 | 23 | ||
| Penta D | 9 | 9 | ||
| Penta E | 7 | 11 | 7 | 11 |
| TH01 | 8 | 9.3 | 8 | 9.3 |
| TPOX | 8 | 11 | 8 | 11 |
| vWA | 14 | 14 | ||
| D6S1043 | 11 | 13 | ||
| D12S391 | 18 | 18 | ||
| D2S441 | 10 | 13 | 10 | 13 |
* STR authentication data of this cell line matches with that of cell lines sourced from ATCC, DSMZ, JCRB, and RIKEN databases.
Conclusion: The STR identification of this cell is correct.
Conclusion: The STR identification of this cell is correct.
FAQ
Which is better for studying PTAFR function, PTAFR Knockout A-549 Cell Line or PTAFR overexpression A-549 Cell Line?
The choice depends on whether you are studying PTAFR's role as the platelet-activating factor (PAF) receptor in lung biology or its emerging functions in lung cancer biology. The Knockout line is the standard tool for asking whether PTAFR is required for PAF-induced signaling — PAFR is a Gq/Gi-coupled GPCR mediating inflammatory and proliferative responses to PAF and structurally related oxidized phospholipids. Overexpression is useful for studying PAFR in cancer contexts.
For lung biology and cancer research, the EDITGENE PTAFR Knockout in A-549 is highly relevant — A-549 is an NSCLC model, and PAFR signaling has been implicated in lung cancer progression, particularly post-chemotherapy where oxidized phospholipids from dying cells activate PAFR on surviving tumor cells. Rescue with wild-type or signaling-deficient PAFR enables structure-function studies. The knockout is a critical specificity control for PAFR antagonists (rupatadine, lexipafant) in research applications.
What are the application scenarios for this model?
Primary applications:
• PAF-induced signaling: intracellular calcium mobilization and ERK activation following PAF stimulation in lung cancer context.
• Chemotherapy-induced tumor regrowth: studies of oxidized phospholipid-PAFR signaling in chemotherapy survivors — emerging mechanism of post-chemotherapy tumor progression.
• Inflammatory response: PAF-induced inflammatory cytokine production and downstream signaling in epithelial context.
• PAFR antagonist specificity: critical genetic control for rupatadine, lexipafant, and other PAFR-targeting compounds.
EDITGENE recommends this model for researchers investigating platelet-activating factor receptor biology, lung cancer-associated PAF signaling, and PAFR-targeted research applications.
Is this PTAFR Knockout A-549 Cell Line compatible with overexpression rescue experiments?
Yes. PAFR rescue experiments require attention to GPCR topology:
• Construct design: use a codon-modified PTAFR sequence with a small intracellular C-terminal tag (FLAG, HA). PAFR is a seven-transmembrane GPCR — preserve extracellular ligand-binding regions.
• Signaling-deficient rescue: DRY motif mutations enable separating ligand binding from intracellular signaling.
• Functional readout: rescue should restore PAF-induced calcium mobilization (Gq-coupled signaling) and ERK activation.
A-549 transduces efficiently with lentivirus and supports stable rescue line generation.
* Research Use Disclaimer: Content is generated from publicly available research data, bioinformatic resources, and computational analyses for research reference only.
download